Recursion Pharmaceuticals (RXRX) Operating Expenses (2020 - 2026)
Recursion Pharmaceuticals (RXRX) recorded Operating Expenses of $142.64 million in Q2 2026, down 27.0% from $195.45 million a year earlier but up 5.7% from the prior quarter.
Powered by 
Analysis
Recursion Pharmaceuticals (RXRX) Operating Expenses (2020 - 2026) Analysis & Trends
On a TTM basis, Recursion Pharmaceuticals' Operating Expenses came in at $598.86 million as of Jun 30, 2026, down 16.2% year-over-year; for FY2025, it was $722.81 million, up 34.4% from FY2024.
- Annual Operating Expenses has increased for six straight years, with a five-year compound annual growth rate of 52.2% (FY2020 to FY2025).
- Across earlier years, Operating Expenses came in at $537.84 million in FY2024 (+36.3%), $394.64 million in FY2023 (+38.2%), $285.57 million in FY2022 (+48.0%) and $192.95 million in FY2021 (+117.8%).
- Quarterly Operating Expenses has ranged from $48.94 million in Q3 2021 to $206.11 million in Q1 2025 over the past five years.
- On a year-over-year basis, Operating Expenses has declined for three consecutive quarters, with growth averaging 24.9% over the last eight quarters.
- Peak year-over-year performance for Operating Expenses in the last five years was growth of 138.7% in Q4 2021, against a decline of 34.5% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $134.98 million (Q1 2026), $143.87 million (Q4 2025) and $177.38 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -6.09 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -9.70 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 6.54 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 18.20 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 6.68 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.09 Bn |
| 10 | Recursion Pharmaceuticals | 1.98 Bn | -627.04 Mn | -3.82 Mn | 142.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 142.64 Mn |
| Mar 31, 2026 | 134.98 Mn |
| Dec 31, 2025 | 143.87 Mn |
| Sep 30, 2025 | 177.38 Mn |
| Jun 30, 2025 | 195.45 Mn |
| Mar 31, 2025 | 206.11 Mn |
| Dec 31, 2024 | 188.31 Mn |
| Sep 30, 2024 | 124.44 Mn |
| Jun 30, 2024 | 114.96 Mn |
| Mar 31, 2024 | 110.13 Mn |
| Dec 31, 2023 | 109.82 Mn |
| Sep 30, 2023 | 110.08 Mn |
| Jun 30, 2023 | 92.73 Mn |
| Mar 31, 2023 | 82.00 Mn |
| Dec 31, 2022 | 74.66 Mn |
| Sep 30, 2022 | 75.73 Mn |
| Jun 30, 2022 | 73.87 Mn |
| Mar 31, 2022 | 61.31 Mn |
| Dec 31, 2021 | 67.49 Mn |
| Sep 30, 2021 | 48.94 Mn |
API Access
Recursion Pharmaceuticals Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();